McGuire Investment Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-57,822
| Closed | -$2.72M | – | 111 |
|
|
2024
Q3 | $2.72M | Sell |
57,822
-48
| -0.1% | -$2.26K | 0.38% | 54 |
|
|
2024
Q2 | $3.13M | Sell |
57,870
-118
| -0.2% | -$6.37K | 0.45% | 51 |
|
|
2024
Q1 | $3.95M | Sell |
57,988
-609
| -1% | -$41.5K | 0.58% | 46 |
|
|
2023
Q4 | $3.67M | Sell |
58,597
-809
| -1% | -$50.6K | 0.61% | 45 |
|
|
2023
Q3 | $2.7M | Buy |
59,406
+2,368
| +4% | +$107K | 0.52% | 47 |
|
|
2023
Q2 | $3.2M | Buy |
57,038
+4,141
| +8% | +$232K | 0.6% | 44 |
|
|
2023
Q1 | $2.39M | Buy |
52,897
+17,048
| +48% | +$771K | 0.48% | 48 |
|
|
2022
Q4 | $1.46M | Buy |
35,849
+31,210
| +673% | +$1.27M | 0.32% | 54 |
|
|
2022
Q3 | $303K | Buy |
4,639
+150
| +3% | +$9.8K | 0.07% | 90 |
|
|
2022
Q2 | $273K | Buy |
4,489
+790
| +21% | +$48K | 0.06% | 96 |
|
|
2022
Q1 | $232K | Buy |
+3,699
| New | +$232K | 0.04% | 112 |
|
|
2021
Q4 | – | Sell |
-2,049
| Closed | -$229K | – | 124 |
|
|
2021
Q3 | $229K | Hold |
2,049
| – | – | 0.04% | 114 |
|
|
2021
Q2 | $332K | Sell |
2,049
-146
| -7% | -$23.7K | 0.06% | 92 |
|
|
2021
Q1 | $267K | Buy |
2,195
+464
| +27% | +$56.4K | 0.06% | 97 |
|
|
2020
Q4 | $265K | Sell |
1,731
-1,050
| -38% | -$161K | 0.07% | 87 |
|
|
2020
Q3 | $233K | Sell |
2,781
-470
| -14% | -$39.4K | 0.07% | 88 |
|
|
2020
Q2 | $239K | Buy |
+3,251
| New | +$239K | 0.08% | 82 |
|